$100m increase in market cap. For data in THREE (3) mice. No wonder Australian biotech is nuts.
" The treatment group (n=3) with established tumours had INV043 injected intratumorally, and
subsequently were illuminated with red light. No anaesthesia was required and no adverse
effects were observed"
Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-100
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $3.286K | 26.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24920 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 9938 | 1 |
View Market Depth
| Last trade - 15.31pm 17/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |